Clever Culture Systems Limited
CC5
Kedudukan dalam Saham
#27506
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Harga Saham
$0.0141057
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$30.78M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
32.83%
Negara
AU
Perdagangan Clever Culture Systems Limited (CC5)
Kategori
Healthcare
Nisbah P/E bagi Clever Culture Systems Limited (CC5)
Nisbah P/E pada October 2026 TTM: -4.25
Menurut laporan kewangan dan harga saham terkini Clever Culture Systems Limited, nisbah P/E semasa (TTM) ialah -4.25. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -0.63.
Sejarah nisbah P/E bagi Clever Culture Systems Limited dari 2005 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | -4.25 | 21.08% |
| 2024 | -3.51 | 459.63% |
| 2023 | -0.63 | -87.74% |
| 2022 | -5.12 | 19.44% |
| 2021 | -4.29 | -68.78% |
| 2020 | -13.73 | 64.96% |
| 2019 | -8.32 | -14.03% |
| 2018 | -9.68 | 6.76% |
| 2017 | -9.07 | -294.61% |
| 2016 | 4.66 | -84.50% |
| 2015 | 30.06 | -37.09% |
| 2014 | 47.78 | 167.38% |
| 2013 | 17.87 | -551.85% |
| 2012 | -3.95 | 2.75% |
| 2011 | -3.85 | -188.81% |
| 2010 | 4.33 | -88.24% |
| 2009 | 36.86 | 34.54% |
| 2008 | 27.40 | 2.54% |
| 2007 | 26.72 | 0.00% |
| 2005 | 0.00 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 36.15 | -950.70% |
US
|
|
| 39.77 | -1,035.85% |
US
|
|
| -290.26 | 6,729.59% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -904.35% |
US
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.